Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

374 ARTÍCULOS , VIENDO DEL 121 AL 135

Multi-targeting Strategies for Alzheimer's Disease Therapeutics: Pros and Cons

Das S, Basu S.

Curr Top Med Chem. 2017;17(27):3017-3061. doi: 10.2174/1568026617666170707130652.

Chinese herbal medicine for Alzheimer's disease: Clinical evidence and possible mechanism of neurogenesis

Yang WT, Zheng XW, Chen S, Shan CS, Xu QQ, Zhu JZ, Bao XY, Lin Y, Zheng GQ, Wang Y.

Biochem Pharmacol. 2017 Oct 1;141:143-155. doi: 10.1016/j.bcp.2017.07.002. Epub 2017 Jul 8.

Amylin Receptor: A Potential Therapeutic Target for Alzheimer's Disease

Fu W, Patel A, Kimura R, Soudy R, Jhamandas JH.

Trends Mol Med. 2017 Aug;23(8):709-720. doi: 10.1016/j.molmed.2017.06.003. Epub 2017 Jul 7.

Astrocyte: An Innovative Approach for Alzheimer's Disease Therapy

Bronzuoli MR, Facchinetti R, Steardo L, Scuderi C.

Curr Pharm Des. 2017;23(33):4979-4989. doi: 10.2174/1381612823666170710163411.

Targeting Human Astrocytes' Calcium-sensing Receptors for Treatment of Alzheimer's Disease

Chiarini A, Armato U, Whitfield JF, Pra ID.

Curr Pharm Des. 2017;23(33):4990-5000. doi: 10.2174/1381612823666170710162509.

A Brief Review of Three Common Supplements Used in Alzheimer's Disease

Spence J, Chintapenta M, Kwon HI, Blaszczyk AT.

Consult Pharm. 2017 Jul 1;32(7):412-414. doi: 10.4140/TCP.n.2017.412.

Current advances in transdermal delivery of drugs for Alzheimer's disease

Nguyen TT, Giau VV, Vo TK.

Indian J Pharmacol. 2017 Mar-Apr;49(2):145-154. doi: 10.4103/0253-7613.208143.

An Overview of New Possible Treatments of Alzheimer's Disease, Based on Natural Products and Semi-Synthetic Compounds

Zanforlin E, Zagotto G, Ribaudo G.

Curr Med Chem. 2017 Nov 17;24(34):3749-3773. doi: 10.2174/0929867324666170712161829.

Natural product for the treatment of Alzheimer's disease

Bui TT, Nguyen TH.

J Basic Clin Physiol Pharmacol. 2017 Sep 26;28(5):413-423. doi: 10.1515/jbcpp-2016-0147.

Antagonism of the 5-HT(6) receptor - Preclinical rationale for the treatment of Alzheimer's disease

de Jong IEM, Mørk A.

Neuropharmacology. 2017 Oct;125:50-63. doi: 10.1016/j.neuropharm.2017.07.010. Epub 2017 Jul 12.

Amyloid beta: structure, biology and structure-based therapeutic development

Chen GF, Xu TH, Yan Y, Zhou YR, Jiang Y, Melcher K, Xu HE.

Acta Pharmacol Sin. 2017 Sep;38(9):1205-1235. doi: 10.1038/aps.2017.28. Epub 2017 Jul 17.

Aquaporin 4 in Astrocytes is a Target for Therapy in Alzheimer's Disease

Lan YL, Chen JJ, Hu G, Xu J, Xiao M, Li S.

Curr Pharm Des. 2017;23(33):4948-4957. doi: 10.2174/1381612823666170714144844.

Therapeutic Agents in Alzheimer's Disease Through a Multi-targetdirected Ligands Strategy: Recent Progress Based on Tacrine Core

Lin H, Li Q, Gu K, Zhu J, Jiang X, Chen Y, Sun H.

Curr Top Med Chem. 2017;17(27):3000-3016. doi: 10.2174/1568026617666170717114944.

Drug candidates in clinical trials for Alzheimer's disease

Hung SY, Fu WM.

J Biomed Sci. 2017 Jul 19;24(1):47. doi: 10.1186/s12929-017-0355-7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias